Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.530
+0.340 (10.66%)
At close: Jun 27, 2025, 4:00 PM
3.500
-0.030 (-0.85%)
After-hours: Jun 27, 2025, 7:47 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $127.03 million as of June 27, 2025. Its market cap has increased by 210.42% in one year.
Market Cap
127.03M
Enterprise Value
95.25M
1-Year Change
210.42%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $127.03M, a decrease of -65.28%. That is a compound annual growth rate of -23.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 99.68M | 45.92% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.13B |
| Johnson & Johnson | 367.00B |
| AbbVie | 326.78B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 278.90B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.12B |
| AstraZeneca | 215.99B |